In this article, the evidence base for botulinum-A treatment acquired in recent years is outlined, and the practicalities involved in providing this service are described. Botulinum-A is relatively new, and possible improvements for the future are considered.
- BT-A, botulinum A
- CP, cerebral palsy
- RCT, randomised controlled trial
- botulinum toxin
- cerebral palsy
Statistics from Altmetric.com
Funding: REM has received research grants from Ipsen, manufacturers of Dysport BT-A.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.